Pacific Sage Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-285
| Closed | -$203K | – | 112 |
|
|
2024
Q4 | $203K | Hold |
285
| – | – | 0.05% | 97 |
|
|
2024
Q3 | $300K | Hold |
285
| – | – | 0.07% | 79 |
|
|
2024
Q2 | $300K | Buy |
285
+1
| +0.4% | +$1.05K | 0.07% | 76 |
|
|
2024
Q1 | $273K | Hold |
284
| – | – | 0.07% | 78 |
|
|
2023
Q4 | $249K | Hold |
284
| – | – | 0.07% | 78 |
|
|
2023
Q3 | $234K | Hold |
284
| – | – | 0.07% | 76 |
|
|
2023
Q2 | $204K | Hold |
284
| – | – | 0.06% | 82 |
|
|
2023
Q1 | $233K | Hold |
284
| – | – | 0.08% | 74 |
|
|
2022
Q4 | $205K | Buy |
+284
| New | +$205K | 0.07% | 83 |
|